CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoBRUSA, Davide
Dettaglio
BRUSA, Davide
SCIENZE MEDICHE
Pubblicazioni
Risultati 1 - 20 di 35 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment | 2015 | Serra, S; Brusa, D; Vaisitti, T; Buonincontri, R; Audrito, V; Coscia, M; Rossi, D; Bhavsar, Eb; Furman, Rr; Gaidano, G; Deaglio, S |
| 2 | Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment | 2016 | Serra, Sara; Vaisitti, Tiziana; Audrito, Valentina; Bologna, Cinzia; Buonincontri, Roberta; Chen, Shih-Shih; Arruga, Francesca; Brusa, Davide; Coscia, Marta; Jaksic, Ozren; Inghirami, Giorgio; Rossi, Davide; Furman, Richard R.; Robson, Simon C.; Gaidano, Gianluca; Chiorazzi, Nicholas; Deaglio, Silvia |
| 3 | Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart | 2007 | D' Hooghe E; Buttiglieri S; Bisignano G; Brusa D; Camussi G; Matera L |
| 4 | Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation | 2009 | Garetto S; Sizzano F; Brusa D; Tizzani A; Malavasi F; Matera L. |
| 5 | CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells | 2011 | Sara Serra; Alberto Horenstein; Tiziana Vaisitti; Davide Brusa; Davide Rossi; Luca Laurenti; Giovanni D'Arena; Marta Coscia; Claudio Tripodo; Giorgio Inghirami; Simon Robson; Gianluca Gaidano; Fabio Malavasi; Silvia Deaglio |
| 6 | CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death | 2011 | Serra S; Horenstein AL; Vaisitti T; Brusa D; Rossi D; Laurenti L; D'Arena G; Coscia M; Tripodo C; Inghirami G; Robson SC; Gaidano G; Malavasi F; Deaglio S. |
| 7 | Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison. | 2013 | Brusa D; Simone M; Gontero P; Spadi R; Racca P; Micari J; Degiuli M; Carletto S; Tizzani A; Matera L |
| 8 | Contribution of dendritic cells FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies | 2007 | SIGNORINO E; BRUSA D; GRANATA R; MALAVASI F; FERRONE S; MATERA L |
| 9 | Correlation between NK function and response to trastuzumab in metastatic breast cancer patients | 2008 | Beano A; Signorino E; Evangelista A; Brusa D; Mistrangelo M; Polimeni MA; Spadi R; Donadio M; Ciuffreda L; Matera L. |
| 10 | Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. | 2015 | Audrito V; Serra S; Brusa D; Mazzola F; Arruga F; Vaisitti T; Coscia M; Maffei R; Rossi D; Wang T; Inghirami G; Rizzi M; Gaidano G; Garcia JG; Wolberger C; Raffaelli N; Deaglio S. |
| 11 | Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism | 2014 | Audrito, V; Serra, S; Brusa, D; Mazzola, F; Arruga, F; Vaisitti, T; Coscia, M; Maffei, R; Rossi, D; Wang, T; Inghirami, G; Rizzi, M; Gaidano, G; Wolberger, C; Raffaelli, N; Deaglio, S |
| 12 | HLA-G is a component of the CLL escape repertoire to generate immune suppression: impact of HLA-G 14 bp (rs66554220) polymorphism | 2014 | R. Rizzo;V. Audrito;P. Vacca;D. Rossi;D. Brusa;M. Stignani;D. Bortolotti;G. D' Arena;M. Coscia;L. Laurenti;F. Forconi;G. Gaidano;M. C. Mingari;L. Moretta;F. Malavasi;S. Deaglio |
| 13 | Immune Trait Shifts in Association With Tobacco Smoking: A Study in Healthy Women | 2021 | Piaggeschi G.; Rolla S.; Rossi N.; Brusa D.; Naccarati A.; Couvreur S.; Spector T.D.; Roederer M.; Mangino M.; Cordero F.; Falchi M.; Visconti A. |
| 14 | Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells | 2009 | BRUSA D; MIGLIORE E; GARETTO S; SIMONE M; MATERA L |
| 15 | iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells | 2009 | De Boo S; Kopecka J; Brusa D; Gazzano E; Matera L; Ghigo D; Bosia A; Riganti C. |
| 16 | The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. | 2015 | Piva, Roberto; Deaglio, Silvia; Famà, R; Buonincontri, Roberta; Scarfò, I; Bruscaggin, A; Mereu, Elisabetta; Serra, Sara; Spina, V; Brusa, Davide; Garaffo, Giulia; Monti, S; Dal Bo, M; Marasca, R; Arcaini, L; Neri, A; Gattei, V; Paulli, M; Tiacci, E; Bertoni, F; Pileri, Sa; Foà, R; Inghirami, Giorgio; Gaidano, G; Rossi, D. |
| 17 | Mir-214 and mir-148b targeting inhibits dissemination of melanoma and breast cancer | 2016 | Orso, Francesca; Quirico, Lorena; Virga, Federico; Penna, Elisa; Dettori, Daniela; Cimino, Daniela; Coppo, Roberto; Grassi, Elena; Elia, Angela Rita; Brusa, Davide; Deaglio, Silvia; Brizzi, Maria Felice; Stadler, Michael B.; Provero, Paolo; Caselle, Michele; Taverna, Daniela |
| 18 | Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. | 2013 | Vaisitti T; Audrito V; Serra S; Bologna C; Arruga F; Brusa D; Buonincontri R; Gizdic B; Deaglio S. |
| 19 | NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. | 2011 | Vaisitti T; Audrito V; Serra S; Bologna C; Brusa D; Malavasi F; Deaglio S |
| 20 | Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells | 2011 | Kopecka J; Campia I; Brusa D; Doublier S; Matera L; Ghigo D; Bosia A; Riganti C |
Copyright © 2022